Media briefing on WHO Council on the Economics of #HealthForAll financing brief
00:00:00
GA Hello, everybody, and thank you for joining this media
briefing. I’m Gabriella Stern; I’m the Director of Communications at the World
Health Organization.
I’m moderating
this presser from Geneva. And in Berlin, at the World Health Summit, we
have Dr Tedros Adhanom Ghebreyesus, the Director General of the World Health
Organization, with Professor Mariana Mazzucato, who is the Chair of the WHO
Council on the Economics of Health For All. But, she is also professor in the
Economics of Innovation and Public Value at University College, London, where
she's also Founding Director of the UCL Institute for Innovation and Public
Purpose.
We have 30 minutes for this press briefing, which is
really going to focus on the Economic Council's new financing brief and the
timing of the brief is quite important as we have the G20 meeting coming up
later this week.
00:01:07
Following the remarks from Dr Tedros and Professor Mazzucato
we'll have time for some media questions and when I come to you in the Q&A
I'll ask you to raise your hand in the Zoom and write in your name and the name
of your outlet so we know who you are and can call on you.
We will be taking questions on the Council and the brief. If you
have unrelated questions we have a presser planned later this week on broader COVID
topics and you can ask unrelated questions at that time.
So without further ado, Dr Tedros, the floor is yours. Thank you.
TAG Thank you. Thank
you, Gabby. Dear colleagues and friends, today I'm pleased to join you for the
presentation of the second policy brief by the WHO Council on the Economics of
Health For All.
We're joined by the Council Chair, Professor Mariana Mazzucato,
who has led this distinguished group of diverse experts from around the world
in their important mission.
00:02:30
Their new brief on financing health for all comes at a critical
time with the upcoming G20 summit in Rome where Professor Mazzucato will
present there Council's findings. It's important to start by defining health
for all and I would like to quote one of my esteemed predecessors as
Director-General of the World Health Organization, Dr Hafden Mahler, who said,
health for all - I quote - implies the removal of the obstacles to health -
that's to say the elimination of malnutrition, ignorance, contaminated drinking
water and unhygienic housing - quite as much as it does the solution of purely
medical problems such as lack of doctors, hospital beds, drugs and vaccines -
end of quote.
A landmark commitment to health for all was made at the Almada
Conference of 1978 and more recently there was the high-level political
declaration on universal health coverage at the UN General Assembly two years
ago.
In the face of this powerful commitment huge challenges remain.
The COVID-19 pandemic has thrown a harsh spotlight on the inequities both
within and between countries. This includes the vast disparities in vaccine
allocation where just one-quarter of the 6.7 billion vaccine doses distributed
globally have gone to lower and low-income countries although they make up more
than half the global population.
Addressing the structural inequalities that keep us from
achieving health for all is not a job for the health sector alone. The COVID-19
pandemic has taught us that the impact of health crises resonates throughout
economies and societies.
00:04:50
It's clear that this goes well beyond the health ministry.
Ministries of finance, trade, labour, infrastructure, environment and so many
others including heads of state, including international financial institutions
and the private sector must be at the table, must take responsibility and
tackle the great challenge of health for all together.
We need a new narrative. We can no longer see health as a cost
but as an investment that's the foundation of productive, resilient and
inclusive economies. The task of the Council is not only to come up with
innovative economic approaches to improve health and well-being.
They must also be practical and applicable to countries of all
income levels. The Council released its first brief on health innovation this
past June. The new policy brief released today on financing health for all
proposes a radical shift in economic thinking for global health.
Instead of looking at health as a piece of the economy it's time
to look at how the economy can support the societal goal of health for all.
This new finance brief shows that neither existing market mechanisms with their
focus on short-term returns nor development funds alone are enough.
They do not provide the global public goods on which we all
depend such as vaccines, nor do they address the major inequities undermining
equitable access. The Council is proposing bold, concrete actions for
governments and multilateral organisations in three major areas, creating
fiscal space, the direction of investment and the governance of public and
private financing for health.
00:07:15
This does not just mean more money. It means making the better,
smarter and sustained investments that are needed to achieve health for all so
more money plus better money, not only the quantity but also the quality.
It's time for a new paradigm. We have to consider financing for
health as a long-term investment, not as a short-term cost. My thanks to
Professor Mazzucato and all Council members for their work. I hope that this
powerful report reaches policymakers in all sectors and at the highest levels.
Thank you and, Gabby, back to you.
GA Thank you, Dr
Tedros. Now we're going to turn to Professor Mariana Mazzucato. Mariana, the
floor is yours.
MM Great. Thank you,
Gabby, and thank you so much, Dr Tedros, for your leadership and the words that
you just had for the WHO Council on the Economics of Health for All. This is,
as you said, our second output. The first one was really how can we innovate
towards the common good, how can we structure the mechanisms of production and
innovation itself in order to actually reach the health for all objective.
00:08:36
This one is really focused on financing mechanisms on the back of
the G7 meeting and the upcoming G20 meeting this week when finance ministers
and health ministers talk about what needs to get done.
We're a council currently composed of ten women economists from
all five continents. We're about to let in some men. I hear that Gordon Brown
is our waiting list. The women themselves are myself, [names].
We formed the Council in May and we are quite driven to make sure
that the messages come at the right time and again this is an incredibly
important moment to make sure that we're not just filling the system with
finance and with liquidity as we did after the financial crisis, when most of
that finance just went back into the financial sector.
How can we make sure the finance actually lands in the real
economy, strengthens global health systems but also that the financial
structures themselves are redesigned? Because we have to learn the mistakes
from the past.
00:09:45
Really this is the core point of the council. We don't think that
there's been any lack of thinking about the relationship between health and
economy. The problem is that often the logic has not been the right one. The
logic has been investment health and it's also good for the economy.
We say no, investment health for all, that's the mission and then
back-track and ask, what does it actually mean for all the different types of
economic structures and the social and economic fabric of society, what does it
mean for how we govern innovation, how we direct and restructure finance, how
we use tools like outcomes-based and participatory budgeting, how we can use it
to really drive innovative procurement.
Procurement budgets are huge within every single government in
terms of the percentage of government spending and yet it's often a static
instrument instead of a dynamic instrument fostering new solutions for public
goals.
What does it also mean in an era like the one we're living in
where there're these huge recovery funds and also bail-outs for different types
of companies, how can we create a real conditionality at the centre of that
creation of money so we truly do what the world is talking about, which is
building back better or building forwards better?
00:11:00
As with climate the cost of inaction is actually greater than not
acting today [sic] and it really requires seeing the kind of investments that
we talk about as investments in the long run and not costs in the short run. By
cutting costs today we're going to create a huge mess that's actually going to
cost us more later.
So what does it actually mean to build back better? One of the
things that we're very clear on in this moment where there is a call for more
finance is that we really, as Dr Tedros already highlighted, have to be
careful, we have to better understand how the current structure of the
financial system and of the economic system got us into this mess in the first
place, including also the climate crisis, the health crisis, the financial
crisis.
On that however we should also be pushing for more finance. We're
not just going to say that we need better finance but on the more finance it's
very important to listen to the G20 report of the high-level independent panel
which currently is calling for an investment in pandemic preparedness as a
global public good, such an important concept I'll repeat it - a global public
good.
00:12:05
They call for a minimum commitment from governments for pandemic
prevention and preparedness to be at least $75 billion over the next five years
in addition to, not instead of, existing development support, the ODA.
What our Council says is yes, yes, yes, we have to increase the
finance. We have been starving global health systems. However we have to do it
in new terms. Finance and financial structures are not neutral. They're not
just greasing the world of commerce. How we structure the financial systems and
the public/private partnerships actually matter and they affect the direction
where the finance actually goes and also the outcomes.
So we really believe that the existing paradigm of economic
thinking itself needs to change. This is why we brought together these amazing
women, many of whom are actually professors of economics, to actually ask, what
is the new economic thinking that also needs to be underpinning better economic
policy.
A lot of the problems have been that the focus on short-termism,
which has then led to cost-cutting, profit maximisation, has also really
dismantled vital capabilities on the ground that have undermined the
strengthening of health systems and the social determinants of health.
00:13:21
So we can't just continue to put in vast amounts of money without
actually questioning what has gone wrong and how can we improve it and these
deep structural issues that need to change.
So we set basically three different pathways that we think are
crucial for rethinking the structures of the financial system itself and I'm
going to briefly review those. First we argue that we need to stop saying that
there is no money.
We need to actually create the fiscal space for health for all
and we can't do it when it's too late. Money has come out of the woodwork
during COVID-19 but it's too late if we're not continuously investing in all
those very important areas that then lead to the mission of health for all.
We argue that internal constraints on government budgets are not
insurmountable and governments have always actually more room for increasing
the fiscal limits on investments for health than they're led to believe.
It's not just a matter of political choice but also one of
political will, whether a country can mobilise all of the resources and levers
it can to maximising financing for health such as innovative monetary policy
but also, as I mentioned before, procurement policies, using all the different
levers - grants, loans, procurement - to really catalyse new solutions that we
need for health for all, which has to be the objective itself.
The bottom line is that countries must reverse the harmful
effects of an austerity approach to public administration and public finance
reforms. It's quite interesting if you look around the world. The countries
that have fared better have also fared better if you look at...
For example Kerala, a region in India, did better based on those
investments that it made within its public administration and there's indeed
external constraints, almost false constraints that have been imposed on
governments' fiscal spaces often by - and let's call it out - multilateral
organisations like the IMF and the World Bank.
00:15:07
Actually the IMF has put out some very important writings in
recent years saying, actually austerity didn't work and it itself has to change
in terms of what kind of conditions it puts on the loans. So let's remember
that mea culpa call that we've seen in recent years with some very important
papers that have come out of the IMF.
The rules of the game are a product of what is often called the
Washington consensus. These are no longer fit for purpose and they must change
to create a much more enabling fiscal environment for long-term equitable
growth and enable social spending to improve individual and collective health
security and ensure progress towards health for all.
Specifically we also propose multilateral organisations should
negotiate debt relief for low and middle-income countries in such an important
moment as the one we're living through, redirecting special drawing rights
towards investment in health and especially vaccines, push for enforcing a
minimum global corporate tax of at least 15% and advance the G20 reform of
sovereign credit ratings.
00:16:07
So that first area's really again creating the fiscal space and
going beyond the myth that there's no money. When we go to war money is found
and during a health pandemic money has been found but that is too little and
too late. We need to rethink the myths themselves.
Second, we need to direct investments towards health for all to
reorient economic activities around health. We need to forge symbiotic
public-private relationships. We need business, we need public actors, we need
philanthropies but they need to work together in a different way.
A way to do that is really to bring together some
conditionalities at the core of a new social contract so conditionalities,
incentives and regulations which have the objectives themselves at the core.
This can be done by redesigning the terms and the conditions structuring
contracts, grants, transfers, loans and partnerships between public and private
actors.
What we focus on also in the first brief on innovation is that
this point is particularly important in health innovation precisely because the
public sector puts in so much of the money, especially in the early stage when
it's more risky and more capital-intensive, uncertain.
00:17:15
So these critical markets shaping public investments should
surely ensure conditionalities around pricing to make sure that we have access
at the core, that we have vaccines that are globally accessible but also how we
structure intellectual property rights that truly reflect the public interest
including the possibility of consistent and long-term financial return and
ownership of research, in other words, that we also share in both the risks and
the rewards instead of what we often find, which is socialisation of risk but
privatisation of rewards.
The issue of structuring intellectual property rights is
important because what we in the end want with innovation is collective
intelligence and so making sure that patents are not too wide, too strong, hard
to license and to upstream are core ways to govern the patent system.
It's not about getting rid of patents. We have to govern
innovation and the patent system with objectives in mind and more broadly we
need to shape a conducive regulatory, tax, industrial and economic policy
environment and create a normative framework to crowd in all sorts of different
sorts of finance at the same time, ensuring that we get the greatest multiplier
effect and the greatest impact on health for all.
00:18:25
Only a truly global end-to-end health innovation platform
governed collectively and shifting from a model where innovation is left to the
market to a model aimed at delivering global common goods - again a very
important word that has also been used by the independent G20 panel.
Third and lastly we say that we need to govern public and private
finance for health for all. Private finance has been an important source of
financing for health products and services but we need better regulations of
private finance to help to ensure that health markets are better aligned with
public health imperatives including universal access to good-quality provision,
prevent excessive charges and rent extraction through monopolies and, as
already discussed, setting intellectual property rules that do not inhibit
critical access and innovation, reducing information asymmetries and preventing
conflicts of interest.
A key action point right now given the gross inequity in the
vaccine distribution, which Dr Tedros has sometimes called a vaccine apartheid
and a huge moral failure in the global system, is to redouble the efforts to
strengthen and invest in existing mechanisms for global vaccine distribution
like COVAX and technology transfer, for instance the COVID-19 Technology Access
Pool, where it's needed, transforming them and they way they are governed to be
more inclusive and able to deliver health for all.
00:19:44
Can I just again thank you, Dr Tedros, for your leadership. Thank
you for allowing us to set up this inspirational panel. We will continue to put
out output. Our next one will actually be on value and it's quite important
right now that while we have these calls by the IMF, the World Bank, the G20,
the G7 for increased financing for pandemic preparedness and response we have
to constantly remind ourselves that more money is important but it's not enough
if we are to change the underlying economic thinking, policies and inequalities
that keep getting us from one crisis to another.
Thank you very much for your time. I'm happy to answer questions.
GA Thank you,
Mariana, thank you, Dr Tedros. Journalists, please raise your hand in the Zoom
if you want to ask a question and again put your name and the name of your news
outlet. We have a few minutes left and while we're waiting for hands to be
raised I'm going to ask you, both of you or whichever of you would like to take
the question, a question that really reflects a lot of discussion in media and
in social media.
During the pandemic there has been, as you alluded to, relatively
little progress in equity and financing issues along the lines of what the
Council is proposing. The brief that you've summarised is very idealistic and
it proposes really transformative steps.
But give the fact that the market economic is so deeply embedded
in most powerful nations is a radical re-engineering really possible? Don't you
think that after the pandemic capitalist societies and most powerful private
and public-sector leaders and players will just go back to their old ways, will
revert to the same-old-same-old and the new social contract you propose will
just be left behind?
00:21:46
MM Can I take that,
Dr Tedros? We can do it together. Maybe I'll start. It's a really good question
and I think there're two parts to your question which are, are we going to go
back to the old way? The answer is we can't, we can't afford to.
But the bigger question is, is this just pie-in-the-sky and is this
just some sort of utopian ideal? I think the answer is no and this is why the
second year actually of the Council - this is still just our first six-month
period - is really going to be focused on implementing these ideas.
One of the ways to do that is actually to start working with
different partners globally who have already begun but just in too much of a
peripheral way to experiment with new structures of finance.
It's quite interesting. Even with the COVID-19 funding globally
some countries like France were quite bold in putting strong conditions
attached to the money that flowed for example to airlines and the automobile
industry. They had to commit to lowering their carbon emissions over the next
five years in order to get that public subsidy.
00:22:47
There's something about that conditionality that we need to be
just normalising. It shouldn't just happen in a period of crisis precisely
because the sector, the health area has so much collective effort and
collective value creation.
What does it mean to design within these partnerships goals and
conditions attached so that we don't just use the word, the market economy, but
actually remember that markets are outcomes of how we govern all the different
actors but especially how we govern the relationship.
That's why in the brief we talk about mutualistic and symbiotic
relationships and not what frankly sometimes in the health area is a parasitic
relationship. Look at the United States where you have $40 billion a year going
in via the national institutes of health and health innovation and somehow the
intellectual property rights don't get governed with respect to that, the
pricing of the drugs again don't take that into account.
So this is actually a global phenomenon that because health is so
important we think that it's enough just to put money in without then governing
it to make sure it actually benefits people.
00:23:53
Another example I'll bring out is the military. The military also
invest in health, soldiers get sick in the war but because we put war as an
urgent battle to win somehow organisations like - again in the US - the
Department of Defense and DARPA, when they fund medicines they make sure
actually that the soldiers get access to the medicine that they actually
finance.
It's because we don't treat as urgent our social problems that we
don't actually get real to make sure that we have global access to these
innovations that we're financing. So I don't like to use the military as an
example because I don't think we can rule by fear but it's interesting that
when we put our minds to it and actually treat things in an urgent way with
what I call a mission orientation we can learn a lot about what has happened in
other sectors.
We need to use COVID-19 as a real wake-up call to do things
differently.
GA Right, thank
you. Anything to add, Dr Tedros? We do have a question from...
00:24:52
TAG I think Mariana
had already said... but the pandemic is unprecedented and if we're not going to
learn lessons from this I think we will repeat the same mistake. This COVID
pandemic has affected the whole world and actually taken the whole world
hostage and destroyed lives and livelihoods, affected our social fabric and
impacted our politics, economy.
I think the world should come back to its senses and learn from
this and implement. Gabby, you said this is idealistic. I wouldn't say that. I
would say this is the right thing to do in order to prevent the next pandemic
and prevent all the crisis that's happening now and still is happening, by the
way.
It has shown health is central and should not be treated as a
cost but should be treated as an investment so everybody has seen it now,
there's direct experience and I hope the world will listen and act.
These recommendations, especially the three pathways are very
clear, creating fiscal space, directing investment to health for all and also
governing the public and private sector.
The commitment to health for all has been there since the
establishment of WHO at the end of the 1940s. In our constitution it's clearly
put there.
00:26:53
I think the world had agreed even then but I don't think it was
serious enough. Probably the lessons we have learned now will - still the same
health for all, nothing has changed but I think will now add seriousness into
what the world agreed in the 1940s.
So health for all is the answer and I think we have learned our
lessons the hard way and we have to listen to the Council that's already
proposing the pathways to a better world. Thank you, Gabby. Back to you.
GA Thank you. We have
a question from Andanaya Ashur of Development Today. Can you ummute and ask
your question, please.
AN Yes, hello. Can
you hear me?
GA Yes.
AN Thank you. You
mentioned COVAX in your presentation and you mentioned one of the
recommendations of the G20 report on pandemic preparedness to invest at least
$75 billion over the next five years in addition to ODA.
What I'd like to ask you about is, in two days the ACT
Accelerator, of which COVAX is a part, will launch a new strategy and budget
for 2022. I have not seen the final version yet but the total bill for
high-income countries will probably be in the region of 40 to $50 billion if we
include the funding gap from this year.
The argument has been made by the IMF and WHO and many others
that it makes economic sense to help low and middle-income countries out of
this pandemic and yet the ACT Accelerator remains badly underfunded.
00:28:53
So what arguments can be made, in your opinion, for high-income
countries to make this funding available and in a timely fashion? Thank you so
much.
GA Thank you. Which
of our distinguished speakers would like to take this question?
MM I think you gave
the answer in your very eloquent question, which is of course that the
high-income countries have to be helping the low-income countries. One of the
things that we talk about in both briefs is that we also need to, at least in
the long run, better understand why it is that the capacity on the ground in
the low-income countries has become so weak. How can we actually change the
business models, the way we innovate and create industrial capacity globally
precisely so we have to rely less on charity at moments like these?
So even though immediately we need solidarity, we need the
high-income countries to do exactly what Dr Tedros set out in his early
remarks, I think in the long run we have to realise that this donor mentality
is actually part of the problem and that lots of the conditionalities that were
set in the past on the loans provided to developing countries precisely made
them weaker actually and they weren't allowed actually to create that kind of
fiscal space that we highlight as the first key pillar.
So over time - because this will not be the last pandemic. As the
permafrost melts apparently there're going to be all sorts of other viruses
that come about so climate change and this health crisis are really interlinked
unfortunately.
00:30:34
So we have to be better-prepared and that preparedness needs to
be a long-run preparedness that really is built on ability to have a
distributed manufacturing capacity and industrial capacity globally and
focusing on the continent of Africa, I think, is going to be extremely
important in that light.
That is why we call out things like the Washington consensus
conditionalities that actually led to that weaker global system in the first
place. So I would say that your recommendation is exactly the right one and
again echoes what Dr Tedros mentioned at the beginning
But it's not enough of itself otherwise we will constantly have
to rely on someone filling the gap and a donor-type mentality, which
unfortunately doesn't actually make the global economic system stronger in a
distributed way.
TAG Thank you. I
think it's covered but just one dimension. We were discussing about the ACT-A financing
plus the G20, be it 25 billion or US$50 billion and I think the world knows
also how much money it's spending on austerity, trillions.
Some finance ministers said what ACT-A is asking is actually a
rounding error for many countries. So 75 billion for five years is really
small, not really big compared to the austerity funding which we see in
especially high-income countries.
00:32:11
So is it because of lack of money? I don't think so. It's not.
Then what is it? I think many colleagues during this World Health Summit have
been saying it. Yesterday also we had a meeting. It's lack of commitment. There
is no real commitment to really act and based on the recommendations implement
and then get the necessary result that we're expecting.
It's actually very disappointing that the ACT-A is not fully
financed because, as the Ministers of Finance said, it's a rounding error, the
amount of money which is being asked and collectively for those to have the
resources it's actually even small because no-one is expecting the funding to
come from one country or two or three countries. It's from all that can afford
to contribute, especially the high-income countries.
So again if there is real commitment there is a way because you
asked me, how can they finance, what are the mechanisms? The mechanism is not
an issue. There are mechanisms that you can use to finance. The problem is the
lack of willingness and commitment to act or low commitment to act.
00:33:42
So we have, as you said, our presser on Thursday when we launch
the strategy, where we can discuss the same thing again if you're joining.
Thank you.
GA We have two more
questions and then we'll wrap up. One is a written question from Gustavo
Captidila of Interpress Service. He asks to you, Mariana, what do you specifically
refer to when you mention - quote - artificial constraints imposed by outdated
economic assumptions - end quote?
MM Sorry. Were you
finished, Gabby? Yes. This idea that government budgets are the same things as
household budgets... A household if it gets into debt must pay back that debt
or it will go bankrupt. That is not the same thing as a government budget.
Governments do, especially those with sovereign currencies, have
the ability to create finance but it's more than just the activities through
bond markets. It's the point that if you can then create a multiplier effect,
which is really what we talked about, the need to have ambitious, bold public
policies that are mission-oriented, that increase also the expectations in the
business community of where future opportunities lie but with strong conditions
attached to make sure there's a common goal, that has a multiplicative power of
creating finance that of course again households don't have.
00:35:20
So this confusion between government budgets and household
budgets is what I'm referring to, that creates this false idea that there's no
money, that you actually have to, say, raise taxes, which of course is
important. We should have a progressive taxation system.
But the actual constraint is often the lack of imagination of
what to finance in the first place. This is why it's important to go back to
Roosevelt's New Deal and the Green Deal that is being talked about today and
really to focus a lot also on the word, the deal.
But really to remember something that Roosevelt talked about,
which we talked about, Dr Tedros, in a meeting recently, which is the need to
experiment and to try, Roosevelt often talked about. Just try something, for
God's sake.
So this is really what both our briefs so far try to do, to
reimagine a different way to structure an economy with health-for-all goals
attached to it which can foster new types of public-private partnerships which
then galvanise more finance towards really important goals around the social
and economic determinants of health as opposed to always pretending that
there's no money.
00:36:27
And then actually money comes again out of the woodwork, lots of
it during crisis when it's too late because this crisis ended up being much,
much worse than it had to be because we didn't properly finance our global
health systems.
GA Thank you. We
have a question and our last question because we are beyond time is from Elaine
Fletcher at Policy Watch. Elaine, can you unmute yourself, please.
EL Yes, thanks. As
Gabby mentioned, this is a very far-reaching brief and a lot of it could be
considered rather pie-in-the-sky so my question would be, as this is coming out
just ahead of the G20 meeting, what would be the three top asks that you'd like
to put to the G20 around these issues, what would you like to see in their
final statement?
I'm wondering if this also revolves around the issues of debt
relief and special drawing rights, which we haven't heard much elaboration
about. I think maybe closing the circle a little more tightly to the health
issue on those questions would be a good connection to make.
00:37:45
GA Excellent. Over
to you, Mariana.
MM Yes. You just
named two of the very important ones which again in the brief we go more into,
which are the debt relief is also because we know... The debt relief that we
called for, which I discussed, is related to this need for new economic
thinking, that just increasing the amount of debt into the system without
actually realising that it's precisely also the conditions that were tied to
that debt which reduce the capacity on the ground is something we have to
reflect on.
This, by the way, is also true more globally in terms of the
loans that have been provided to different types of companies globally. This
has only increased private debt and the ratio of private debt to disposable
income right now globally is back to the level it was with the financial
crisis.
So the mechanisms themselves that are often used at moments like
these to try to get to of the crisis just start laying the groundwork for the
next crisis so that's a bigger point but it's a very important point because
unfortunately what we're seeing in many different countries is an increase in
private debt.
But in terms of the public debt we call for debt relief precisely
so this fiscal space in such a crucial moment can be created and we make very
specific points around that.
00:39:07
In terms of SDRs, do you want to mention them? No? Being able to
actually direct the SDRs that are created by these large multilateral
institutions is very important. This point that we need to be directing the
finance towards particular objective is crucial because otherwise you have
SDRs, which in theory are there to help lower-income countries, but if they are
not structured in such a way and targeted in such a way around making sure that
we have globally accessible vaccines and not the current situation of vaccine
apartheid, that requires structuring those SDRs in a much more rounded and
specific way than simply assuming that the fact that they exist will help us
out of the crisis.
But I think this point of also realising, if we look at the
vaccines for example, there're lots of different vaccines out there but they
were actually structured in different ways and I don't think there's been
enough discussion about that.
The fact that for example - and I don't want to call out specific
ones or make reference to good versus bad but just the attention to the design
detail matters and we need to make sure we're learning from the positive experiences.
The fact that the AstraZeneca vaccine for example represented
actually strong negotiation between the public researchers at Oxford University
and the company, keeping costs low and making sure that we didn't have storage
systems that just made them inefficient and hot countries but also that the IPR
is much weaker and so on.
These are all lessons that we should be learning from in terms
of, going forward, what works, what doesn't and it's just important in a G20
moment that we don't just use big words like vaccines - and remember that the
actual mission is not just having a vaccine, it's making sure that it's again
globally accessible.
00:41:03
That means not just the solidarity that's required, that we were
just talking about, in terms of making sure that they are sent to countries
that haven't had the first and second jabs, but also that we produce and
innovate in fundamentally different ways in the first place, which limits the
kind of rent-seeking that we've seen in the past.
GA Thanks, Mariana.
Dr Tedros, any thoughts on the upcoming G20 and beyond?
TAG Yes, on the G20
of course we have to focus on ending this pandemic so one focus area should be
on how to finance the vaccination targets. We have to vaccinate the world. The
target is 40% by the end of this year and 70% by the middle of next year in
each and every country.
So the G20's commitment to this will be very important. If we
cannot be serious about ending the pandemic and at least financing the
vaccination campaign I don't think anybody will trust us if we commit about the
future or investments, about preparedness for the future.
If we're serious we start from fulfilling this immediate need. So
real commitment to that, to achieve the 40% by the end of this year and 70% by
the middle of next will be crucial and should be the focus.
00:42:48
Of course in addition to that discussions for the future pandemic
treaty and agreement on a pandemic treaty or a pandemic agreement will be very
important. Then of course the centrality of health is now clear. Investment in
emergency preparedness, investment in health systems in general, commitment to
health for all as per this brief will be very, very important, and of course
agreeing or committing to financing those.
One thing that's put forward specifically again is the
recommendation from a high-level panel organised by the G20 countries that came
up with a set of recommendations and to form a health and finance board which
can mobilise resources to fund pandemic preparedness and response.
This is a very good idea and WHO supports this fully and I hope
the G20 countries can agree on this proposal. I had many rounds of discussions
with the panel of experts and we're convinced that this could be a good support
to global health in general and also to emergency preparedness and response in
particular.
00:44:31
So I think these are the areas among others but if you ask me in
terms of immediate it's the vaccine now, finance and achieve the targets, end
the pandemic, open the world - that's one.
Second is to agree on the G20 health and financing board which is
proposed by the high level, which can help us mobilise more resources as per
the proposal already set forward. These two could be at the centre and of
course the rest of what we have discussed [unclear] will show if there is a
real commitment there because these are the immediate - do them today and show
that you are serious, is the issue. Thank you.
GA Thanks, Dr
Tedros. Thank you, Professor Mazzucato. To quote you, Dr Tedros, if not now
when? With that I'll wrap up the press conference. To reporters who joined,
thank you. We will send you by email the audio file from this presser.
Later today there is a session at the World Health Summit in
Berlin on the Council for the Economics of Health for All, which will be
live-streamed, which our two distinguished speakers will join and other VIPs. I
hope you can tune into that, which we will also be live-streaming on our
accounts.
Last but not least, we will have a press conference on Thursday
and, as Dr Tedros and one of our reporters from Development Today indicated,
ACT Accelerator will be a topic of conversation at that time.
So see you there. Thank you again and goodbye and have a great
day.
00:46:18